Macrophage-Derived Chemokine and EBI1-Ligand Chemokine Attract Human Thymocytes in Different Stage of Development and Are Produced by Distinct Subsets of Medullary Epithelial Cells: Possible Implications for Negative Selection1

The chemoattractant activity of macrophage-derived chemokine (MDC), EBI1-ligand chemokine (ELC), and secondary lymphoid tissue chemokine (SLC) on human thymocytes was analyzed. Both ELC and SLC caused the accumulation of CD4+CD8− or CD4−CD8+ CD45RA+ thymocytes showing high CD3 expression. By contrast, a remarkable proportion of MDC-responsive thymocytes were CD4+CD8+ cells exhibiting reduced levels of CD8 or CD4+CD8− cells showing CD3 and CD45R0, but not CD45RA. MDC-responsive thymocyte suspensions were enriched in cells expressing the MDC receptor, CCR4, selectively localized to the medulla, and in CD30+ cells, whereas ELC-responsive thymocytes never expressed CD30. Reactivity to both MDC and ELC was localized to cells of the medullary areas, but never in the cortex. Double immunostaining showed no reactivity for either MDC or ELC by T cells, macrophages, or mature dendritic cells, whereas many medullary epithelial cells were reactive to MDC or ELC. However, MDC reactivity was consistently localized to the outer wall of Hassal’s corpuscles, whereas ELC reactivity was often found in cells surrounding medullary vessels, but not in Hassal’s corpuscles. Moreover, while most MDC-producing cells also stained positive for CD30L, this molecule was never found on ELC-producing cells. We suggest therefore that CD30L-expressing MDC-producing medullary epithelial cells attract CCR4-expressing thymocytes, thus favoring the CD30/CD30L interaction, and therefore the apoptosis, of cells that are induced to express CD30 by autoantigen activation. By contrast, ELC production by CD30L-lacking medullary epithelial cells may induce the migration into periphery of mature thymocytes that have survived the process of negative selection.

[1]  Á. Zaballos,et al.  Cutting edge: identification of the orphan chemokine receptor GPR-9-6 as CCR9, the receptor for the chemokine TECK. , 1999, Journal of immunology.

[2]  C. Campagnoni,et al.  The human myelin basic protein gene is included within a 179-kilobase transcription unit: expression in the immune and central nervous systems. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[3]  H. Griesser,et al.  Impaired Negative Selection of T Cells in Hodgkin's Disease Antigen CD30–Deficient Mice , 1996, Cell.

[4]  N. Taylor,et al.  Human thymocytes express CCR-3 and are activated by eotaxin. , 1999, Blood.

[5]  T. Bonner,et al.  Brief Definitive Report Identification of CCR8: A Human Monocyte and Thymus Receptor for the CC Chemokine I-309 , 2022 .

[6]  H. Broxmeyer,et al.  CCR7 ligands, SLC/6Ckine/Exodus2/TCA4 and CKbeta-11/MIP-3beta/ELC, are chemoattractants for CD56(+)CD16(-) NK cells and late stage lymphoid progenitors. , 1999, Cellular immunology.

[7]  H. Nomiyama,et al.  Molecular Cloning of a Novel Human CC Chemokine EBI1-ligand Chemokine That Is a Specific Functional Ligand for EBI1, CCR7* , 1997, The Journal of Biological Chemistry.

[8]  James J. Campbell,et al.  Human G Protein–Coupled Receptor Gpr-9-6/Cc Chemokine Receptor 9 Is Selectively Expressed on Intestinal Homing T Lymphocytes, Mucosal Lymphocytes, and Thymocytes and Is Required for Thymus-Expressed Chemokine–Mediated Chemotaxis , 1999, The Journal of experimental medicine.

[9]  N. Copeland,et al.  TECK: a novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T cell development. , 1997, Immunity.

[10]  C. Thompson,et al.  Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines. , 1998, Journal of immunology.

[11]  C. Power,et al.  Molecular cloning of murine CC CKR-4 and high affinity binding of chemokines to murine and human CC CKR-4. , 1996, Biochemical and biophysical research communications.

[12]  H. Broxmeyer,et al.  TECK, an efficacious chemoattractant for human thymocytes, uses GPR-9-6/CCR9 as a specific receptor. , 1999, Blood.

[13]  L. Cosmi,et al.  Macrophage‐derived chemokine production by activated human T cells in vitro and in vivo: preferential association with the production of type 2 cytokines , 2000, European journal of immunology.

[14]  J. Sprent,et al.  B7 expression on thymic medullary epithelium correlates with epithelium-mediated deletion of V beta 5+ thymocytes. , 1994, Journal of immunology.

[15]  G. Suzuki,et al.  Pertussis toxin-sensitive signal controls the trafficking of thymocytes across the corticomedullary junction in the thymus. , 1999, Journal of immunology.

[16]  A. Rudensky,et al.  Medullary Thymic Epithelium: A Mosaic of Epithelial “Self”? , 1998, The Journal of experimental medicine.

[17]  P. Allavena,et al.  Divergent effects of interleukin-4 and interferon-gamma on macrophage-derived chemokine production: an amplification circuit of polarized T helper 2 responses. , 1998, Blood.

[18]  M. Dorf,et al.  Identification of a new mouse beta-chemokine, thymus-derived chemotactic agent 4, with activity on T lymphocytes and mesangial cells. , 1997, Journal of immunology.

[19]  R. Flavell,et al.  Reciprocal regulation of CD30 expression on CD4+ T cells by IL-4 and IFN-gamma. , 1997, Journal of immunology.

[20]  J. Westwick,et al.  Chemokines and T lymphocytes: more than an attraction. , 1998, Immunity.

[21]  M. Kasai,et al.  Medullary but not cortical thymic epithelial cells present soluble antigens to helper T cells , 1992, The Journal of experimental medicine.

[22]  M. Juan,et al.  Transcription of a broad range of self-antigens in human thymus suggests a role for central mechanisms in tolerance toward peripheral antigens. , 1998, Journal of immunology.

[23]  L. Cosmi,et al.  Opposite role for interleukin‐4 and interferon‐γ on CD30 and lymphocyte activation gene‐3 (LAG‐3) expression by activated naive T cells , 1997, European journal of immunology.

[24]  C. Kurts,et al.  Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells , 1999, Nature.

[25]  T. Mcclanahan,et al.  Identification through bioinformatics of two new macrophage proinflammatory human chemokines: MIP-3alpha and MIP-3beta. , 1997, Journal of immunology.

[26]  S. Berrih-Aknin,et al.  Expression of acetylcholine receptor genes in human thymic epithelial cells: implications for myasthenia gravis. , 1996, Journal of immunology.

[27]  James G. Boyd,et al.  Interferon–inducible T Cell Alpha Chemoattractant (I-TAC): A Novel Non-ELR CXC Chemokine with Potent Activity on Activated T Cells through Selective High Affinity Binding to CXCR3 , 1998, The Journal of experimental medicine.

[28]  G. Inghirami,et al.  CD30 overexpression enhances negative selection in the thymus and mediates programmed cell death via a Bcl-2-sensitive pathway. , 1999, Journal of immunology.

[29]  J. White,et al.  Differential chemotactic behavior of developing T cells in response to thymic chemokines. , 1998, Blood.

[30]  C. Bordignon,et al.  Expression of CXCR4, the receptor for stromal cell‐derived factor‐1 on fetal and adult human lymphohematopoietic progenitors , 1999, European journal of immunology.

[31]  E. Butcher,et al.  Cutting edge: developmental switches in chemokine responses during T cell maturation. , 1999, Journal of immunology.

[32]  L. Klein,et al.  CD4 T Cell Tolerance to Human C-reactive Protein, an Inducible Serum Protein, Is Mediated by Medullary Thymic Epithelium , 1998, The Journal of experimental medicine.

[33]  P. Gray,et al.  Macrophage-derived chemokine is localized to thymic medullary epithelial cells and is a chemoattractant for CD3(+), CD4(+), CD8(low) thymocytes. , 1999, Blood.

[34]  P. Leder,et al.  IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo , 1993, The Journal of experimental medicine.

[35]  T. Boone,et al.  Molecular Cloning and Functional Characterization of a Novel CC Chemokine, Stimulated T Cell Chemotactic Protein (STCP-1) That Specifically Acts on Activated T Lymphocytes* , 1997, The Journal of Biological Chemistry.

[36]  P. Allavena,et al.  Human Macrophage–derived Chemokine (mdc), a Novel Chemoattractant for Monocytes, Monocyte-derived Dendritic Cells, and Natural Killer Cells , 1997 .

[37]  A. Luster,et al.  Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.

[38]  J. Todd,et al.  Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus , 1997, Nature Genetics.

[39]  F. Annunziato,et al.  High CD30 ligand expression by epithelial cells and Hassal's corpuscles in the medulla of human thymus. , 1998, Blood.

[40]  J. Ashwell,et al.  Constitutive expression of interferon gamma-inducible protein 10 in lymphoid organs and inducible expression in T cells and thymocytes , 1994, The Journal of experimental medicine.

[41]  Y. Sakaki,et al.  A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes. , 1997, Journal of immunology.

[42]  E. Wolf,et al.  CCR7 Coordinates the Primary Immune Response by Establishing Functional Microenvironments in Secondary Lymphoid Organs , 1999, Cell.

[43]  D. Ho,et al.  In Vivo Distribution of the Human Immunodeficiency Virus/Simian Immunodeficiency Virus Coreceptors: CXCR4, CCR3, and CCR5 , 1998, Journal of Virology.

[44]  O. Yoshie,et al.  Molecular Cloning of a Novel T Cell-directed CC Chemokine Expressed in Thymus by Signal Sequence Trap Using Epstein-Barr Virus Vector* , 1996, The Journal of Biological Chemistry.

[45]  M. Baggiolini Chemokines and leukocyte traffic , 1998, Nature.

[46]  T. Honjo,et al.  Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. , 1993, Science.